Authors
Latest:
Complexities With SMN2 Copies in Spinal Muscular Atrophy: Basil Darras, MDThe associate neurologist-in-chief at Boston Children’s Hospital discussed the 4-copy conundrum and whether treatment decisions differ based on SMN2 copies for patients with spinal muscular atrophy. [WATCH TIME: 2 minutes]
Latest:
Key Insights from ACTRIMS Forum 2025: Diagnostic Criteria, Imaging, and MS SubtypesExperts discussed recent advancements in diagnostic criteria, imaging techniques, and the evolving understanding of multiple sclerosis subtypes and treatment responses. [WATCH TIME: 10 minutes]
Latest:
Kate Davis, MD, MSTR: Increasing Treatment Options for Epilepsy PatientsThe epileptologist at the University of Pennsylvania spoke about the multiple options for patients with epilepsy and the need for a better understanding of choosing from the options.
Latest:
FDA Approves Riptide Aspiration System for Acute Ischemic StrokeThe FDA has approved the Riptide Aspiration System for thrombus retrieval via the Arc Catheter for revascularization in patients with acute ischemic stroke secondary to intracranial large vessel occlusive disease.
Latest:
Marking a New Era in Patient Care With Advancements in Disease-Modifying Alzheimer Treatments: Alireza Atri, MD, PhDThe director of the Banner Sun Health Research Institute talked about how the newly approved Alzheimer treatments have shown promise in slowing clinical decline, signaling a foundational shift toward disease-modifying therapies that target core biological processes. [WATCH TIME: 5 minutes]
Latest:
Pediatric Sleep Disorders: Assessment and TreatmentThe long-term consequences of untreated—and prevalent—sleep disorders in children and adolescents point to a need for a focus on this field of care.
Latest:
David Langer, MD: Answering the Call for COVID-19The chair of neurosurgery at Lenox Hill Hospital in Manhattan recently joined the ranks of health care providers who are caring for COVID-19 patients at the temporary hospital set up in the Javits Center.
Latest:
Tessa Blanken, MSc: Identification of Robust, Clinically Relevant Insomnia SubtypesThe identification of the subtypes allows future studies to target homogeneous subtype samples, resolve inconsistencies, personalize treatment and utilize preventive interventions.
Latest:
Marc Nuwer Explores the 2019 CPT Codes for EpilepsyThe professor and vice chair of the neurology department at UCLA discussed the new VNS, RNS and DBS CPT codes for 2019.
Latest:
Joshua Cohen, MD: Fremanezumab's Impact on Quality of Life and ComorbiditiesThe Global Medical Lead for Migraine and Headache at Teva Pharmaceuticals provided insight into how fremanezumab has helped to improve these facets of the condition.
Latest:
Eight Ways to Evaluate a Telehealth VendorA look at the questions you should be asking during the decision-making process of picking a telehealth vendor.
Latest:
Zachary Grinspan, MD, MS: Collaborating Across Specialties to Improve OutcomesThe director of the Pediatric Epilepsy Program and an MD candidate at Weill Cornell Medicine detail the steps needed to take to improve outcomes in status epilepticus.
Latest:
Sharon Chiang, MD, PhD: Recording Seizures With Detection TechnologyThe neurology resident at the University of California San Francisco discussed how new wearable technology and electronic diaries have helped improve the understanding of seizure rhythmicity, and ultimately, epilepsy care.
Latest:
Screening for Alzheimer Disease: Facilitating an Early Diagnosis for Prompt InterventionIn this episode of MEDcast, expert geriatric psychiatrists explore the urgent need for effective diagnostic methods that can detect Alzheimer’s disease at an early stage. We will discuss blood-based biomarkers and other advancements that can help screen Alzheimer’s disease non-invasively and early in the disease course.
Latest:
Edward Wild, MBBChir, PhD, MA: Generation HD1 Study of RG6042The neurologist at the Huntington’s Disease Center at University College London spoke about the clinical development of RG6042 in the treatment of Huntington disease, and what to expect from the GENERATION HD1 study.
Latest:
William Tatum, DO: When to Obtain a Routine EEG While Managing a Patient with EpilepsyThe neurologist and epileptologist at the Mayo Clinic in Jacksonville spoke about how to best identify adult patients in need of routine EEG and what it will bring to the table relative to the clinician.
Latest:
Potential Promise Behind ATH434 for Multiple System Atrophy: Daniel Claassen, MD, MSThe director of the Huntington’s Disease Clinic at Vanderbilt University Medical Center gave commentary on the unique development of ATH434, its ability to target iron accumulation, and how it may slow disease progression in multiple system atrophy. [WATCH TIME: 3 minutes]
Latest:
Peter Goadbsy, MD, PhD, DSc: Atogepant Has Potential as Migraine ProphylacticThe professor of neurology at both the University of California San Francisco and King’s College, London, spoke about the results from a phase 2b/3 study evaluating atogepant for prevention of migraine.
Latest:
CNM-Au8 as a Novel Therapeutic Category in MS: Robert Glanzman, MDThe chief medical officer at Clene Nanomedicine discussed the recently presented data on CNM-Au8 from the VISIONARY-MS trial.
Latest:
Properly Integrating Newly Approved IPX203 in the Care of Parkinson DiseaseThe panelists provided clinical insight on the utilization of IPX203, its potential benefits and clinical implications, as well as the practicalities of transitioning patients from other therapies.
Latest:
Future Directions for the Management of NarcolepsyMargaret Park, MD, and Russell Rosenberg, PhD, DABSM, provide clinical pearls and the future treatment landscape for the management of narcolepsy.v
Latest:
Spinal Muscular Atrophy and COVID-19: Guidance and Resources for ProvidersAdvocacy organization Cure SMA provides guidance for health care providers caring for patients with SMA during the ongoing COVID-19 pandemic.
Latest:
Analyzing Cognitive Profiles in Multiple Sclerosis and Alzheimer Disease: Le Hua, MDThe director of the Multiple Sclerosis Program at the Cleveland Clinic’s Lou Ruvo Center for Brain Health discussed findings from a study that compared cognitive profiles between patients with multiple sclerosis and Alzheimer disease. [WATCH TIME: 5 minutes]
Latest:
Ruth Ann Marrie, MD, PhD: Role of Comorbidities in MSThe professor of medicine and community health sciences at the University of Manitoba spoke about the effects of comorbidity on diagnosis, outcomes, and treatment in multiple sclerosis.
Latest:
Practical Advice for Managing Morning OFF Episodes in Parkinson DiseaseClosing out his review of on-demand therapies for morning OFF episodes in Parkinson disease, Peter A. LeWitt, MD, shares practical advice for community neurologists.
